SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Andreas Samson who wrote (19185)3/2/1999 8:33:00 PM
From: VLAD  Read Replies (1) of 23519
 
Andreas,

The stock price of Vivus currently tells us that the a domestic partner is nowhere in sight.

I expect that if the speculation regarding Astra/Zeneca partnering with and eventually buying out Vivus is true then we should know more for sure within 30 to 60 days after the merger is complete.

What if the Astra share holders vote not to merge come March 18th? It would seem unwise for either Zeneca or Astra to be negotiating seperate deals with other companies while they are in the midsts of a probable merger. I also assume they may have a verbal agreement not to negotiate any other deals until the merger is complete. A deal that is good for Astra alone may not be good for Astra/Zeneca and a deal that is good for Zeneca alone may also not be in the best interest of Astra/Zeneca. They are already being required to give up certain rights to certain drugs so they don't create a monopoly on certain drug types.

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News